King Charles III is admitted to a clinic for a scheduled prostate operation

King Charles III is admitted to a clinic for a scheduled prostate operation


King Charles III in Camberley, England.

Dan Kitwood | Getty Visuals Enjoyment | Getty Illustrations or photos

King Charles III was admitted to a non-public London hospital Friday to go through a “corrective treatment” for an enlarged prostate, Buckingham Spot said.

The 75-yr-old king will be taken care of at the London Clinic, where by the Princess of Wales is recovering soon after undergoing stomach surgery. The king frequented Kate at the healthcare facility right after he arrived.

“The King was this morning admitted to a London clinic for scheduled therapy,” the palace said. “His Majesty would like to thank all individuals who have despatched their good needs about the previous week.”

Charles, who acceded to the throne 16 months ago, was identified with the benign affliction on Jan. 17 soon after likely for a look at-up because he was dealing with indications. He canceled engagements and was urged to relaxation in advance of the process.

The publicity around the king’s surgical procedure is viewed as an opportunity to encourage other adult men to have their prostates checked in line with community health and fitness suggestions.

The palace claimed the king was “delighted to understand that his analysis is getting a optimistic effects on general public health and fitness consciousness.”



Resource

Nvidia quietly bought a competitor last week. Why analysts believe this could be big deal for the stock
World

Nvidia quietly bought a competitor last week. Why analysts believe this could be big deal for the stock

Nvidia has considerable room to run after spending billions of dollars on assets from artificial intelligence accelerator chipmaker Groq — a deal that analysts think can give its graphics-processing units an edge over competitors. Groq announced its $20 billion “non-exclusive licensing agreement” with Nvidia on Wednesday, marking the largest such deal in the semiconductor manufacturer’s […]

Read More
Wharton’s Jeremy Siegel thinks the market’s gain next year will be much more modest. Here’s why
World

Wharton’s Jeremy Siegel thinks the market’s gain next year will be much more modest. Here’s why

Wharton professor emeritus Jeremy Siegel believes that the stock market’s surge higher will finally lose some of its momentum next year. The benchmark S & P 500 is on pace for a nearly 18% gain for 2025. But in 2026, Siegel expects, the index — which is still heavily weighted towards technology stocks — could […]

Read More
I study couples and money: If you and your partner make just one money move in 2026, do this
World

I study couples and money: If you and your partner make just one money move in 2026, do this

This is the season when everyone’s planning for next year. When it comes to money, I can assure you that the secret isn’t in some fancy investing tactic, hot stock tip, or obscure cryptocurrency.  If you and your partner set just one money resolution for 2026, make it this: You both stay actively involved in […]

Read More